Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology
- 2 April 2020
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 51 (2) , 199-208
Abstract
Neuropilin-1 (NRP-1) is known to be related to various types of cancer and is considered a novel tumor marker or therapeutic target. The aim of this study was to identify the clinical implications of NRP-1 expression in terms of prognosis in patients with gastric cancer. A total of 265 patients who underwent radical gastrectomy for the treatment of gastric cancer from 2008 to 2011 were included in this retrospective study. NRP-1 expression of tumors was determined by immunohistochemistry. The patients’ clinicopathological characteristics, operative details, and long-term outcomes were retrospectively analyzed. A total of 181 (68.3%) patients demonstrated expression of NRP-1. No survival difference was observed according to NRP-1 expression in any patient. The patients were divided into the gland formation (GF) and the no gland formation (nGF) types, according to histology. NRP-1 expression rates were 65.6% (84/128) and 70.8% (97/137), respectively. NRP-1 expression was not an independent prognostic factor in the GF group, although patients who expressed NRP-1 had better survival outcomes. In contrast, patients who expressed NRP-1 in the nGF group had worse 5-year survival rates (p = 0.027), and NRP-1 was an independent prognostic factor in a multivariate analysis (hazard ratio, 1.923; 95% confidence interval, 1.041–3.551). NRP-1 expression in patients with nGF type gastric cancer is predictive of a poor prognosis.Keywords
This publication has 50 references indexed in Scilit:
- Neuropilin 1 guides regulatory T cells into VEGF-producing melanomaOncoImmunology, 2013
- Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological typesWorld Journal of Surgical Oncology, 2012
- The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell AdenocarcinomaAnnals of Surgery, 2011
- MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cellsOncogene, 2010
- Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivityBritish Journal of Cancer, 2010
- Mucinous gastric carcinomasCancer, 2009
- MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cellsBreast Cancer Research and Treatment, 2009
- Chondroitin sulphate‐modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas‐mediated pathwayEMBO Reports, 2008
- Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor GrowthCancer Cell, 2007
- Prognostic significance of mucinous component in colorectal carcinomaTechniques in Coloproctology, 2004